HMH Partners with Medtech Company Neosoma for Innovation in Brain Tumor Treatment Research

Updated:
November 9, 2023
Published:
February 27, 2023

What You Need To Know

  • HMH’s new partnership with Neosoma, a Boston-based medtech company that uses artificial intelligence to research and treat brain tumors, encompasses data-sharing, clinical research and strategic investment by HMH.
  • Neosoma’s innovative method of imaging, tracking and collecting data on numerous types of brain tumors, including glioblastomas, will help HMH physicians with some of the most difficult medical diagnoses.
  • Neosoma recently received FDA clearance for an AI-based neuro-health software device that produces precise and accurate brain tumor analysis on MRIs.

JFK Physicians Will Be First To Use The New Technology

HMH physicians will use Neosoma’s software in clinical practice, beginning with those at Hackensack Meridian JFK University Medical Center – leaders in brain tumor surgery and treatment. The technology will help physicians:
  • Plan procedures
  • Assess post-procedural results
  • Guide chemo and immunotherapy treatments
  • Track patients longitudinally
  • Avoid unnecessary surgeries and interruptions in care
  • Improve treatment and patient experience
“We are committed to investing in research and innovative therapies to live our mission to transform healthcare and give our patients the best possible outcomes,’’ said Robert C. Garrett, FACHE, chief executive officer of Hackensack Meridian Health. “Partnering with Neosoma Inc., is a great way to continue to develop potential game changing therapies to treat these challenging cancers."

Part of HMH's Bear's Den Program to Accelerate Innovation

“We are proud to support promising companies through the Bear’s Den, which accelerates innovation at key points in the pipeline,” said Ihor Sawczuk, M.D., FACS, Hackensack Meridian Health’s president of Academics, Research and Innovation, founding chair of the Hackensack Meridian Health Research Institute, and also associate dean of Clinical Integration and professor and chair emeritus of Urology at the Hackensack Meridian School of Medicine.